Update of the Belgian Association for the Study of the Liver guidelines for the treatment of chronic hepatitis C genotype 1 with protease inhibitors

Acta Gastroenterol Belg. 2012 Jun;75(2):245-59.
No abstract available

Publication types

  • Practice Guideline

MeSH terms

  • Genotype
  • Hepacivirus / genetics*
  • Hepatitis C, Chronic / drug therapy*
  • Humans
  • Oligopeptides / therapeutic use*
  • Proline / analogs & derivatives*
  • Proline / therapeutic use
  • Protease Inhibitors / therapeutic use*

Substances

  • Oligopeptides
  • Protease Inhibitors
  • telaprevir
  • N-(3-amino-1-(cyclobutylmethyl)-2,3-dioxopropyl)-3-(2-((((1,1-dimethylethyl)amino)carbonyl)amino)-3,3-dimethyl-1-oxobutyl)-6,6-dimethyl-3-azabicyclo(3.1.0)hexan-2-carboxamide
  • Proline